Project-26-NanoLoom

NanoLoom aims to revolutionize drug discovery and molecular diagnostics by developing an imaging-based microfluidic platform that analyzes DNA-protein interactions at the single-molecule level. It combines nanoimprint-based microfluidic chips for DNA stretching and imaging, TIRF microscopy for visualizing molecular dynamics, and AI-powered software tools for quantitative analysis of protein binding and drug effects, providing a high-throughput, cost-efficient alternative to existing biochemical assays. Funded by the Eurostars-3 programme by Horizon Europe. (2025-Present)